Hormone replacement therapy is associated with decreased survival in women with lung cancer.
about
Lung cancer chemoprevention: current status and future prospectsMenopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers StudyEstrogen receptor signaling in lung cancerPopulation-based trends in lung cancer incidence in womenEarly changes in pulmonary gene expression following tobacco exposure shed light on the role of estrogen metabolism in lung carcinogenesisTargeting the estrogen pathway for the treatment and prevention of lung cancerThe role of estrogen, progesterone and aromatase in human non-small-cell lung cancerLung cancer in womenExploring estrogenic activity in lung cancerDNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle studyEarly changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue.Identification of collaboration patterns of dysfunctional pathways in breast cancer.Lung cancer screening: a review of available data and current guidelines.Lung cancer in women: role of estrogensLung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.Survival in women with NSCLC: the role of reproductive history and hormone use.Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women.Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.Significance of the progesterone receptor and epidermal growth factor receptor, but not the estrogen receptor, in chemically induced lung carcinogenesis in female A/J mice.Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis.Estrogen adversely affects the prognosis of patients with lung adenocarcinoma.Progesterone and estrogen receptor expression and activity in human non-small cell lung cancerPilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy30th german cancer congress, 22nd-25th february 2012, berlin.Sex differences and sex steroids in lung health and disease.Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumabNuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltrationPrevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.Prediagnosis soy food consumption and lung cancer survival in womenSteroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinomaThe growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism.Paclitaxel poliglumex (PPX, CT-2103): macromolecular medicine for advanced non-small-cell lung cancer.Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed?Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development.Targeting aromatase and estrogen signaling in human non-small cell lung cancer.Antiproliferative effect of exemestane in lung cancer cells.Smoking out reproductive hormone actions in lung cancer.Estrongenic steroid hormones in lung cancer.
P2860
Q26995495-ACE04BF5-71AD-42B4-A0E5-BE962AC450A8Q28391500-B8F1C748-A4CC-4729-B2B6-A8F9867E14B9Q28393484-78A784EC-8E60-40A7-B0D5-35D69572E10DQ28394485-F8E4E901-021C-4266-AC21-4DFBF2B41C34Q28396012-2C972AA9-79C9-4DCB-8CFC-CCFDC17AC40BQ28397456-B3808CA0-38E5-44F9-877E-4E14656C2F55Q28397662-EBA9C37A-266A-4D08-AAD8-0409EE691E63Q29248783-F21A6E2B-C881-43FD-90A9-C63FEDA505DCQ29248785-C1384245-CB60-486A-A4DA-AB253DCA3609Q30494942-D8C506F6-345D-4DEF-BFD2-16E33BFB3614Q33770389-0B072EFC-0EB4-4624-ADDE-544FDD2EE3E7Q33958919-9F0A862C-DBAA-4261-82B4-BD4143EAD60BQ34028990-0B07EEBB-1A4D-47FC-BD61-0CF3E5DBAE0AQ34067949-2204F209-7581-4949-8E94-BEC011DEB7F9Q34083747-8A16F1EA-E5D0-43B6-A5B2-FF4BE7F653FAQ34145853-9C4D14B7-E4DE-4E6A-B3D8-45A0656D024EQ34235471-C398725F-087F-4471-BE69-0CF264E8D4FDQ34310409-FE83B32F-9A27-4A78-8AF6-A98022B12EE9Q34370566-896B4706-0A21-48E5-989D-45472A276164Q34427354-981299C0-A498-421F-91F6-8506270FB250Q34963585-A4900FC5-B92B-4A69-BE0C-8279D12A0A26Q35051314-A131BA7D-75EF-4032-A5B9-A37F21CD9CA9Q35085764-C48BF482-70EC-4C93-AB21-3A1EF72790B8Q35187806-D6A3B375-265A-4234-80CA-FBB281170656Q35250302-6B9A48E9-ED99-4CAA-90DA-E90E7074ABD1Q35883058-D31C2CE5-8FEC-4A4F-8D35-B004F16CEBC7Q36003356-7AF9D7E2-2766-41E2-AC62-87BCABABCCE7Q36286698-3DA27921-8676-4A4D-8096-D7B741630DFBQ36413817-78F20FF3-16F2-4E13-AF26-DAFB4E4D7482Q36646986-1E7D2D96-7FB6-493D-81B7-BC314A42D885Q36763839-AFEC9E4D-2E46-4214-AA95-E510349C0B91Q36775374-E112741C-D2B5-4FBC-8E08-AFE83E9B7EB1Q36782636-97A4878B-5916-404B-919B-C6A38431658BQ36788450-C27F2356-11AC-4DE7-8A80-6E50860C5D6CQ37225785-F5FF82F3-EF88-494E-866D-EEEA9A6164B9Q37354444-E01F2BAF-AA6B-414E-8880-288B60A6A74DQ37435616-2DA3C514-C1BE-4825-A0C7-A9C48874EAA7Q37460552-9C26E591-48C4-4F88-B48E-5EC3F69E06B7Q37679479-836C3F7E-49A7-4BB3-9031-5E6869328F82Q37726987-648AAD96-921B-431E-BBFF-B323DF066D1E
P2860
Hormone replacement therapy is associated with decreased survival in women with lung cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hormone replacement therapy is ...... val in women with lung cancer.
@ast
Hormone replacement therapy is ...... val in women with lung cancer.
@en
type
label
Hormone replacement therapy is ...... val in women with lung cancer.
@ast
Hormone replacement therapy is ...... val in women with lung cancer.
@en
prefLabel
Hormone replacement therapy is ...... val in women with lung cancer.
@ast
Hormone replacement therapy is ...... val in women with lung cancer.
@en
P2093
P356
P1476
Hormone replacement therapy is ...... ival in women with lung cancer
@en
P2093
Abe E Sahmoun
Amit W Panwalkar
Anil Potti
Ketki K Tendulkar
P356
10.1200/JCO.2005.02.9827
P407
P577
2005-11-28T00:00:00Z